Company type | Public |
---|---|
Nasdaq: ZYXI | |
Industry | Medical Technology |
Founded | 1996 |
Founder | Thomas Sandgaard |
Headquarters |
Meridian, Colorado, U.S. |
Products | Medical devices |
Revenue | US$158.2 million (2022) [1] |
US$17 million (2022) [2] | |
Number of employees | 1100 (2023) |
Subsidiaries | Zynex Medical, Inc. Zynex Neurodiagnostics, Inc. Zynex Monitoring Solutions, Inc. Zynex Billing and Consulting, LLC Zynex Europe ApS. |
Website |
zynex |
Zynex, Inc. is a medical device manufacturer that produces and markets electrotherapy devices for use in pain management, physical rehabilitation, neurological diagnosis and cardiac monitoring. [3] [4] [5] [6] Thomas Sandgaard founded Zynex Medical in 1996. [5]
The company is based in unincorporated Douglas County, Colorado. [7] Thomas Sandgaard serves as the company's CEO. [8]
In 1996, Thomas Sandgaard founded Zynex Medical as a wholesaler of electrotherapy products. [9] [10] Sandgaard began working with medical devices in his native Denmark and immigrated to the United States with plans to open a medical devices business. [8] He launched his company in a one-bedroom apartment with $4,000 and a credit card. [4] [11] In 1998, the company received its first Food and Drug Administration approval for one of its products, “an electric-stimulation device that managed pain and increased blood circulation to promote healing.” [8]
The company went public in 2004. [8] In 2008, the company changed its name from Zynex Medical Holdings to Zynex and began trading on the OTC Bulletin Board under the symbol ZYXI. [9] It relocated from Lone Tree, Colorado to Englewood, Colorado in early 2018. [12]
In February 2010, Zynex restructured its business into three subsidiaries: Zynex Medical, Zynex Monitoring Solutions and Zynex NeuroDiagnostic. [13] [14] Zynex Medical manufactures electrotherapy devices for pain management and physical rehabilitation; Zynex Monitoring Solutions manufactures devices for non-invasive cardiac monitoring; and Zynex NeuroDiagnostic manufactures devices for neurological diagnosis. [3] [4]
In March 2012, Zynex Medical acquired the assets of NeuroDyne Medical. [15] NeuroDyne Medical was a Cambridge, Massachusetts-based manufacturer of “medical devices for non-invasive measurement of surface electromyography and autonomic nervous systems.” [15] NeuroDyne Medical was folded into Zynex's NeuroDiagnostic subsidiary. [3] [15]
In February 2019, Zynex Medical began trading on Nasdaq under the symbol ZYXI. [16]
In February 2020, Zynex received FDA clearance for their CM-1500 Cardiac Monitor. [17] [18]
Company type | Public |
---|---|
Nasdaq: ZYXI | |
Industry | Medical Technology |
Founded | 1996 |
Founder | Thomas Sandgaard |
Headquarters |
Meridian, Colorado, U.S. |
Products | Medical devices |
Revenue | US$158.2 million (2022) [1] |
US$17 million (2022) [2] | |
Number of employees | 1100 (2023) |
Subsidiaries | Zynex Medical, Inc. Zynex Neurodiagnostics, Inc. Zynex Monitoring Solutions, Inc. Zynex Billing and Consulting, LLC Zynex Europe ApS. |
Website |
zynex |
Zynex, Inc. is a medical device manufacturer that produces and markets electrotherapy devices for use in pain management, physical rehabilitation, neurological diagnosis and cardiac monitoring. [3] [4] [5] [6] Thomas Sandgaard founded Zynex Medical in 1996. [5]
The company is based in unincorporated Douglas County, Colorado. [7] Thomas Sandgaard serves as the company's CEO. [8]
In 1996, Thomas Sandgaard founded Zynex Medical as a wholesaler of electrotherapy products. [9] [10] Sandgaard began working with medical devices in his native Denmark and immigrated to the United States with plans to open a medical devices business. [8] He launched his company in a one-bedroom apartment with $4,000 and a credit card. [4] [11] In 1998, the company received its first Food and Drug Administration approval for one of its products, “an electric-stimulation device that managed pain and increased blood circulation to promote healing.” [8]
The company went public in 2004. [8] In 2008, the company changed its name from Zynex Medical Holdings to Zynex and began trading on the OTC Bulletin Board under the symbol ZYXI. [9] It relocated from Lone Tree, Colorado to Englewood, Colorado in early 2018. [12]
In February 2010, Zynex restructured its business into three subsidiaries: Zynex Medical, Zynex Monitoring Solutions and Zynex NeuroDiagnostic. [13] [14] Zynex Medical manufactures electrotherapy devices for pain management and physical rehabilitation; Zynex Monitoring Solutions manufactures devices for non-invasive cardiac monitoring; and Zynex NeuroDiagnostic manufactures devices for neurological diagnosis. [3] [4]
In March 2012, Zynex Medical acquired the assets of NeuroDyne Medical. [15] NeuroDyne Medical was a Cambridge, Massachusetts-based manufacturer of “medical devices for non-invasive measurement of surface electromyography and autonomic nervous systems.” [15] NeuroDyne Medical was folded into Zynex's NeuroDiagnostic subsidiary. [3] [15]
In February 2019, Zynex Medical began trading on Nasdaq under the symbol ZYXI. [16]
In February 2020, Zynex received FDA clearance for their CM-1500 Cardiac Monitor. [17] [18]